Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Advanced liposomal vectors as cancer vaccines in melanoma immunotherapy.
Adamina M, Schumacher R, Zajac P, Weber WP, Rosenthal R, Groeper C, Feder C, Zurbriggen R, Amacker M, Spagnoli GC, Oertli D, Heberer M. Adamina M, et al. Among authors: zajac p. J Liposome Res. 2006;16(3):195-204. doi: 10.1080/08982100600848546. J Liposome Res. 2006. PMID: 16952874
Rapid induction of specific cytotoxic T lymphocytes against melanoma-associated antigens by a recombinant vaccinia virus vector expressing multiple immunodominant epitopes and costimulatory molecules in vivo.
Oertli D, Marti WR, Zajac P, Noppen C, Kocher T, Padovan E, Adamina M, Schumacher R, Harder F, Heberer M, Spagnoli GC. Oertli D, et al. Among authors: zajac p. Hum Gene Ther. 2002 Mar 1;13(4):569-75. doi: 10.1089/10430340252809856. Hum Gene Ther. 2002. PMID: 11874634
Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial.
Adamina M, Weber WP, Rosenthal R, Schumacher R, Zajac P, Guller U, Frey DM, Oertli D, Zuber M, Heberer M, Spagnoli GC. Adamina M, et al. Among authors: zajac p. Contemp Clin Trials. 2008 Mar;29(2):165-81. doi: 10.1016/j.cct.2007.07.002. Epub 2007 Jul 17. Contemp Clin Trials. 2008. PMID: 17707139 Clinical Trial.
Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U, Adamina M, Bolli M, Weber WP, Zajac P, Groeper C, Reschner A, Feder C, Schumacher R, Marti W, Oertli D, Heberer M, Spagnoli GC. von Holzen U, et al. Among authors: zajac p. Int J Cancer. 2005 Jun 10;115(2):248-55. doi: 10.1002/ijc.20858. Int J Cancer. 2005. PMID: 15688403 Free article.
135 results